In a very former study, Yammine and her colleagues examined the effects of the prolonged-launch GLP-1 agonist, as well as nicotine substitution therapy, in assisting those who had prediabetes or were overweight quit cigarette smoking.Anybody who has ever had a significant hypersensitivity response to liraglutide or to any from the product factors o